APR 23, 2016 7:57 AM PDT

Surgeons Stimulate Torn ACLs to Self-Heal with a Sponge

WRITTEN BY: Xuan Pham
Each year, surgeons perform roughly 100,000 reconstruction procedures on torn anterior cruciate ligaments (ACLs). This knee injury is most commonly acquired during sports activities that involve rapid stopping and pivoting. ACL reconstructions are notorious for having a long healing time and a high risk for arthritis in the later years.
 
To improve patient outcome with minimal invasiveness, orthopedic surgeons at the Boston’s Children Hospital (BCH) developed a technique that uses the body’s own repair mechanisms to fix the torn ligament. The procedure is hailed as a “game-changer” in the field, as it could significantly shorten the healing time from the 6-9 months to as little as 3 months. Furthermore, the new technique eliminates the need to take tendons and ligaments from other parts of the body.
 
Dr. Martha MurrayMartha Murray, orthopedic surgeon at BCH, pioneered the procedure that’s named Bridge-Enhanced ACL Repair (BEAR). The procedure relies on a bio-enhanced sponge that’s placed in between the torn ends of ligaments, providing a so-called bridge for the ligament to grow into. The sponge is then infused with the patient’s own blood, which clots and stimulates a natural healing process. Surgeons then pull the ends of the torn ligament into the sponge, and over time, the ends heal and connect back to each other. The sponge is replaced by the healing tissue.



The inspiration for BEAR came from when Murray observed how other ligaments in the body heal itself. In particular, she found the medial collateral ligament of the knee self-healed with the help of a blood clot that joined the ends together. But because joint fluid prevents a natural clot from forming at ACL tears, she had to devise a scaffold to connect the tears.
 

As she hoped, the sponge yielded impressive results in preclinical trials. Her team then moved to a Phase 1 trial that included 20 patients with torn ACLs, 10 of whom received the BEAR procedure while the other 10 received the standard ACL reconstruction.
 
Though both groups are rehabilitating well, the BEAR-treated group notably recovered sooner, as they did not have their hamstring tendon removed for use as graft. “The safety study showed us that this is possible,” said Murray. “The ACL can regenerate and come back. We can let our body do what it does so well. We can give it a little piece of machinery like the sponge bridge, rather than taking stuff out and putting something else in like a tendon graft and forcing it to do something that’s not quite as natural. I’m hoping that the BEAR will shift how people look at ACL surgery.”
 
No one in the BEAR-treated group reported infections or knee stiffness. Additionally, if her animal trial results hold up in the patients, those treated with BEAR may have lower risks of arthritis in the repaired knee. Currently, it’s estimated that nearly 80 percent of patients with ACL tears will develop osteoarthritis within 14 years of the injury. A reduction in this risk will be another huge added benefit to the already minimally invasive BEAR procedure.
 
But experts caution that it’s still too soon to make conclusions. “It has the potential to be a game-changer, but it’s still early in the process,” said Jo Hannafin, a sports medicine surgeon at New York City’s Hospital for Special Surgery. “These patients will have to be followed for a minimum of two years to determine whether the ACL heals and does that healed ACL stay competent or stretch over time and fail.”
 
Meanwhile, Murray and her team are proceeding with Phase 2 of the trial. This time, they will enroll 100 patients for a randomized trial in which two-thirds will receive the BEAR treatment. With positive results, Murray hopes the procedure will be more widespread and available in the next three to four years.

Additional sources: Boston Globe
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 07, 2020
Cancer
Immune-Related Genes as Prognostic Biomarkers
AUG 07, 2020
Immune-Related Genes as Prognostic Biomarkers
Cancer is one of the most persistent and hardy diseases. Cancers often develop the ability to suppress the immune system ...
AUG 15, 2020
Genetics & Genomics
How Dermatitis is Linked to Increased Risk of Food Allergies
AUG 15, 2020
How Dermatitis is Linked to Increased Risk of Food Allergies
Small changes in the genome can sometimes have a huge impact, and researchers have found two that increase the risk of e ...
SEP 15, 2020
Cell & Molecular Biology
Autism Spectrum Disorder Biomarker is Discovered
SEP 15, 2020
Autism Spectrum Disorder Biomarker is Discovered
Scientists may have identified a biomarker for autism spectrum disorder, which can be difficult to differentiate from ot ...
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
OCT 17, 2020
Clinical & Molecular DX
Imaging Innovation Set to Ease the Pain of Osteoarthritis
OCT 17, 2020
Imaging Innovation Set to Ease the Pain of Osteoarthritis
In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness ...
DEC 01, 2020
Clinical & Molecular DX
Breathing New Life Into COVID Diagnostics
DEC 01, 2020
Breathing New Life Into COVID Diagnostics
Widespread diagnostic testing capacities are an absolutely critical tool for countries battling the pandemic. For now, m ...
Loading Comments...